Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Choline Nutrient Content Claims Approved By FDA, Will Begin Appearing Soon

This article was originally published in The Tan Sheet

Executive Summary

Choline nutrient content claims will likely begin appearing on product labeling in the next six months, Constance Geiger, PhD, University of Utah, said at a press conference in Washington, D.C. Sept. 10.

You may also be interested in...


FDA authorizes nutrient content claims for substance, allowing food, supplement labels to "characterize the level of choline," agency announces in notice expected to be published in Federal Register the week of Sept. 10. Acceptable claims include: "Good source of choline," "Contains choline," "Rich in choline," "Excellent source of choline" and "High in choline," along with statement such as: "Contains [X mg] choline per serving, which is [X%] of the Daily Value for choline (550 mg)." Ruling results from amended nutrient content notification submitted under FDAMA by Central Soya, which cited National Academy of Sciences' Dietary Reference Intakes standard for choline as "an authoritative statement that identifies the choline level to which the claims refer"

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts